| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-06-03 15:13 Tx date 2025-06-02 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+7,644 vol |
318,489 | |
| Filed 2025-06-03 15:08 Tx date 2025-05-29 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+263,200 vol |
310,845 | |
| Filed 2025-02-14 14:35 Tx date 2025-02-12 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Preferred Shares
16 - Acquisition or disposition under a prospectus exemption
|
$1,000,000
+100 vol $10,000 each |
100 | |
| Filed 2025-02-14 14:34 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Preferred Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-11-01 17:31 Tx date 2024-10-30 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Pardeep Nijhawan Medicine Professional Corporation (Indirect Ownership)
|
Preferred Shares
16 - Acquisition or disposition under a prospectus exemption
|
$1,500,000
+150 vol $10,000 each |
150 | |
| Filed 2024-11-01 17:30 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Pardeep Nijhawan Medicine Professional Corporation (Indirect Ownership)
|
Preferred Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-11-01 17:30 Tx date 2024-10-30 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Pardeep Nijhawan Medicine Professional Corporation (Indirect Ownership)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$40,820
+326,560 vol $0.125 each |
326,560 | |
| Filed 2024-11-01 17:29 Tx date 2019-06-07 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Pardeep Nijhawan Medicine Professional Corporation (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-11-01 17:25 Tx date 2023-12-23 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Pardeep Nijhawan Medicine Professional Corporation (Indirect Ownership)
|
Warrants Class A Purchase Warrants
55 - Expiration of warrants
|
-16,305 vol |
0 | |
| Filed 2024-11-01 17:23 Tx date 2023-12-23 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: The New Nijhawan Family Trust 2015 (Indirect Ownership)
|
Warrants Class A Purchase Warrants
55 - Expiration of warrants
|
-16,305 vol |
0 | |
| Filed 2024-10-02 19:45 Tx date 2024-10-02 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+3,300 vol |
47,645 | |
| Filed 2024-09-06 11:35 Tx date 2024-09-03 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+3,055 vol |
44,345 | |
| Filed 2024-08-07 20:03 Tx date 2023-10-11 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
37 - Stock split or consolidation
|
-85,114 vol |
14,186 | |
| Filed 2024-01-13 11:15 Tx date 2023-10-11 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
37 - Stock split or consolidation
|
-82,206 vol |
||
| Filed 2024-08-02 13:30 Tx date 2024-08-01 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+3,317 vol |
44,198 | |
| Filed 2024-07-10 23:08 Tx date 2024-07-02 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+4,015 vol |
40,881 | |
| Filed 2024-06-04 15:08 Tx date 2024-06-03 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+4,785 vol |
36,866 | |
| Filed 2024-05-06 15:30 Tx date 2024-05-01 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+3,083 vol |
32,081 | |
| Filed 2024-04-02 10:21 Tx date 2024-04-01 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+3,253 vol |
28,998 | |
| Filed 2024-03-29 16:44 Tx date 2024-03-25 |
$EDSA
Edesa Biotech, Inc. |
Nijhawan, Pardeep
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Pardeep Nijhawan Medicine Professional Corporation (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,000
+5,000 vol $4.00 each |
341,702 |